Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
absolute, Akero, appeal, AUC, BID, billing, biomarker, blanket, broadening, carryforward, coincide, congressional, content, culture, depict, diarrhea, District, EDP, embedded, Fitch, GGT, GI, GSK, half, hemisphere, Hepion, histological, IDWeekTM, inclusion, Inline, instance, intent, invoicing, judge, LD, led, Lipocine, Louisiana, MAVIRETTM, Metacrine, NaN, nasal, nonemployee, numerical, Page, pangenotypic, pharmacodynamic, plaque, Poxel, preferentially, QD, quantitative, ready, relocation, RSVP, skin, southern, strain, stream, stronger, subscription, topline, unconstitutional, unrestricted, vendor, Vir, viremic, vomiting, week, worsening
Removed:
AASLD, abbreviation, Ablynx, acting, Allergy, Alnylam, altering, antibody, barrier, bicyclic, bridged, Buckley, choice, clarify, classification, comparability, conclusion, copied, deductible, delinquent, division, earning, elevation, elongation, emerged, enzymatic, equally, excluding, eXtensible, formatted, geographic, hospitalized, itching, Jr, Language, leased, lipoprotein, lung, monoclonal, multiplying, NIH, NS, obligated, outlay, permissible, physiology, polymerase, processing, profound, recruiting, remote, replicate, ribavirin, selective, shape, simplify, Stephen, survive, translated, underway, unproven, vi
Filing tables
Filing exhibits
Related press release
Associated ENTA transcripts
ENTA similar filings
Filing view
External links
Exhibit 21.1
Enanta Pharmaceuticals, Inc.
Subsidiaries of the Company
NAME |
| PARENT |
| STATE OR COUNTRY OF INCORPORATION |
|
|
|
|
|
Enanta Pharmaceuticals Security Corporation |
| Enanta Pharmaceuticals, Inc. |
| Massachusetts |